Saturday 17 October 2026
Export THC’s income statement to Excel — free account
Tenet Healthcare Corporation
THC Healthcare Medical Care Facilities
In the quarter to June 2026, revenue grew 14.6%, EPS grew 213.0%, free cash flow fell 43.9% and total debt was flat, each against the same quarter a year earlier. Revenue growth for three consecutive years.
268.62
6.51
−2.37%
Follow THC
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
13.81 | 12.73 | 9.73 | 7.16 |
P/S ratio |
0.86 | 0.84 | 0.75 | 0.69 | |
P/FCF ratio |
11.89 | 7.08 | 4.89 | 5.17 | |
P/Operating CF |
16.88 | 24.51 | 9.98 | 26.71 | |
P/B ratio |
3.09 | 2.98 | 2.44 | 2.38 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
1.35 | 1.32 | 1.22 | 1.18 | |
EV/EBITDA |
6.49 | 6.42 | 5.58 | 4.90 | |
EV/Operating CF |
11.33 | 7.97 | 6.10 | 6.65 | |
EV/FCF |
18.69 | 11.15 | 7.95 | 8.83 | |
Quick Ratio |
1.20 | 1.22 | 0.91 | 0.86 | |
Current Ratio |
1.71 | 1.76 | 1.36 | 1.41 | |
Net Debt/EBITDA |
9.18 | 9.45 | 6.69 | 6.43 | |
Debt/Assets |
44.83% | 44.38% | 42.33% | 43.19% | |
Debt/Equity |
2.28 | 2.19 | 1.97 | 2.02 | |
Asset Turnover |
0.71 | 0.73 | 0.72 | 0.76 | |
Operating CF/Net income |
3.09 | 1.97 | 2.34 | 0.71 | |
Capex/Depreciation |
(1.25) | (1.54) | (0.77) | (0.76) | |
Interest Coverage |
4.32 | 4.16 | 6.32 | 7.36 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.43 | 0.42 | 0.41 | 0.41 | |
Share Based Compensation of Revenue |
0.72% | 0.45% | 0.43% | 0.73% | |
Graham Net Nets |
(0.89) | (0.88) | (0.98) | (1.04) | |
Graham Number |
147.47 | 153.11 | 183.69 | 214.80 | |
Earnings Yield |
7.24% | 7.86% | 10.28% | 13.96% | |
Free Cash Flow Yield |
8.41% | 14.12% | 20.45% | 19.35% | |
Revenue per Share |
60.14 | 61.31 | 66.60 | 72.33 | |
Operating CF per Share |
12.03 | 8.11 | 18.91 | 7.00 | |
Capex per Share |
(3.18) | (4.04) | (2.07) | (2.01) | |
Free Cash Flow per Share |
8.85 | 4.07 | 16.83 | 4.99 | |
Cash per Share |
33.83 | 31.98 | 34.18 | 25.98 | |
Shareholders Equity per Share |
65.75 | 66.74 | 77.34 | 78.50 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
65.75 | 66.74 | 77.34 | 78.50 | |
Free Cash Flow |
778.00 | 367.00 | 1,461.00 | 417.00 | |
Working Capital |
3,250.00 | 3,386.00 | 2,204.00 | 2,260.00 | |
Capital Expenditures |
(280.00) | (364.00) | (180.00) | (168.00) | |
Net Current Asset Value |
(15,825.00) | (15,811.00) | (16,134.00) | (16,292.00) | |
EV/EBIT |
8.08 | 8.04 | 6.90 | 5.88 | |
Capex to Sales |
0.05 | 0.07 | 0.03 | 0.03 | |
Price to Operating Income |
5.14 | 5.11 | 4.24 | 3.44 | |
| Other line items | |||||
Average Receivables |
2,558.00 | 2,550.50 | 2,612.00 | 2,570.50 | |
Average Payables |
1,310.50 | 1,327.00 | 1,333.00 | 1,365.50 | |
Average Inventory |
351.00 | 347.00 | 343.50 | 338.00 | |
Average Assets |
29,395.00 | 29,306.50 | 30,220.00 | 29,687.50 | |
Average Common Equity |
5,604.50 | 5,918.50 | 6,295.00 | 6,016.50 |
Columns are period end dates